VOYA Investment Management
ORMP icon

VOYA Investment Management’s Oramed Pharmaceuticals ORMP Stock Holding History

VOYA Investment Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,508
Closed -$108K – 2858
2022
Q1 		$108K Buy
12,508
+1,069
+9% +$11K ﹤0.01% 2507
2021
Q4 		$163K Buy
11,439
+148
+1% +$3.09K ﹤0.01% 2573
2021
Q3 		$248K Buy
11,291
+549
+5% +$9.35K ﹤0.01% 2451
2021
Q2 		$144K Buy
+10,742
New +$123K ﹤0.01% 2687

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VOYA Investment Management's ORMP Position: Q2 2022 in Review

VOYA Investment Management sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 12,508 shares — an estimated $108K sold.

VOYA Investment Management first reported a position in ORMP in Q2 2021 and held it in 4 quarters. The position peaked at $248K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • VOYA Investment Management reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 12,508 Oramed Pharmaceuticals shares in Q2 2022, an estimated $108K.
  • VOYA Investment Management first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • VOYA Investment Management's Oramed Pharmaceuticals position peaked at $248K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.